Date:
Saturday, February 7, 2026

Time:
7:30AM - Registration/ Continental Breakfast

8:30AM - Program Starts

2:30PM - Program Concludes

Venue:
Loews Atlanta Hotel, 1065 Peachtree St. NE, Atlanta, GA  30309

Registration Fees: 
Physician: $75
Nurse/Nurse Practitoner/Physician Assistant: $35
Resident/Fellow: $25
Industry: $300

Regional Directors:
Jane Meisel, MD 
Kevin Kalinsky, MD

Preliminary Agenda

7:30 AM - 8:30 AMRegistration, Continental Breakfast, Exhibits Open  
8:30 AM - 8:45 AMWelcome and Introduction of Program and Faculty Pre-Knowledge AssessmentJane Meisel, MD
Kevin Kalinsky, MD, MS		Jane Meisel, MD Kevin Kalinsky, MD, MS
8:45 AM - 9:15 AMBreast Cancer Survivorship and Approaches to Risk Reduction Neil Iyengar, MDNeil Iyengar, MD
9:15 AM - 9:45 AMTranslational Research and Resistance Mechanisms Shipra Ghandi, MD, MSShipra Ghandi, MD, MS
9:45 AM - 10:15 AMBiomarker Discoveries and Molecular SignaturesSunil Badve, MD, FRCPathSunil Badve, MD, FRCPath
10:15 AM - 10:30 AMPanel Question and Answer Session  
10:30 AM - 10:45 AMRefreshment Break with Exhibitors  
10:45 AM - 11:15 AMNovel TherapeuticsHatem Soliman, MDHatem Soliman, MD
11:15 AM - 11:45 AMAdvances in Approaches to Local-Regional DiseasePuneet SiSIngh, MD, MS, FACSPuneet SiSIngh, MD, MS, FACS
11:45 AM - 12:45 PMLunch Break and Supported Symposium - Exhibits Open  
12:45 PM - 1:15 PMUpdates in Early Breast CancerErica Mayer, MDErica Mayer, MD
1:15 PM - 1:45 PMUpdates in Metastatic Breast CancerKomal Jhaveri, MD, FACP, FASCOKomal Jhaveri, MD, FACP, FASCO
1:45 PM - 2:00 PMPanel Question and Answer Session  
2:00 PM - 2:15 PMClinical Controversies and Case Studies  
2:15 PM - 2:30 PMWrap-up and Post Test  
2:30 PMAdjournment  

Program Overview

Breast cancer research continues to advance scientific and clinical knowledge of the disease and bring new techniques, treatments, and strategies to practicing clinicians. As such, clinicians need to stay current with best practices and clinical updates in prevention, screening, diagnosis, and treatment of breast cancer. Understanding results from recent clinical trials and key topics in breast cancer will help clinicians optimize management of patients with breast cancer and ultimately improve patient outcomes.

Learning Objectives

After participating in the Best of SABCS®️ program, learners will be able to:

1.⁠ ⁠INTERPRET recent advancements and research in breast cancer diagnosis, treatment, and specific considerations to enhance the care and outcomes of a diverse community of cancer patients.


2.⁠ ⁠LEVERAGE recent developments in the assessment and management of breast cancer subtypes to identify the most appropriate treatment strategies for people with breast cancer.


3.⁠ ⁠CONSTRUCT risk-adapted management strategies to optimize patient satisfaction, adherence, and treatment efficacy.


4.⁠ ⁠INTEGRATE new evidence from clinical trials in all aspects of breast cancer care presented during poster presentations and educational sessions at the annual San Antonio Breast Cancer Symposium into clinical practice in order to improve patient care.

Target Audience

This official Best of SABCS program is directed to practicing oncologists (medical, surgical, radiation), community physicians, medical residents and fellows training in oncology, as well as other pertinent healthcare professionals involved in oncology medicine.

Accreditation Statement

The University of Texas at San Antonio is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide
continuing medical education for physicians.

The University of Texas at San Antonio has approved this program for AMA PRA Category 1 Credit™.

This Program is Supported with Educational Grants from:
AstraZeneca, Exact Sciences, Lilly, Novartis, and Stemline/Menarini

Interested in Exhibiting?
www.bestofsabcs.com/sponsorship